We are looking for children 2–17 years of age to join a CD medical research study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or moderate to severe Crohn’s disease (including associated symptoms such as rectal pain, unexplained weight loss, diarrhea, weight loss and/or anemia), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child qualifies.
